These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 7839438
21. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A. Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184 [Abstract] [Full Text] [Related]
22. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection? el Gamel A, Keevil B, Rahman A, Campbell C, Deiraniya A, Yonan N. J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869 [Abstract] [Full Text] [Related]
23. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients. Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ. Clin Transplant; 2004 Mar; 18 Suppl 12():61-6. PubMed ID: 15217410 [Abstract] [Full Text] [Related]
26. Immunosuppression in live-related donor renal transplantation. Iman A, Rao M, Juneja R, Jacob CK. Natl Med J India; 2001 Mar; 14(2):75-80. PubMed ID: 11396322 [Abstract] [Full Text] [Related]
27. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis. Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW. Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948 [Abstract] [Full Text] [Related]
35. Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients. Stallone G, Infante B, Schena A, Battaglia M, Ditonno P, Loverre A, Gesualdo L, Schena FP, Grandaliano G. J Am Soc Nephrol; 2005 Dec 15; 16(12):3755-62. PubMed ID: 16236802 [Abstract] [Full Text] [Related]
36. Sirolimus, a new, potent immunosuppressive agent. Kelly PA, Gruber SA, Behbod F, Kahan BD. Pharmacotherapy; 1997 Dec 15; 17(6):1148-56. PubMed ID: 9399599 [Abstract] [Full Text] [Related]
38. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats. Stepkowski SM, Napoli KL, Wang ME, Qu X, Chou TC, Kahan BD. Transplantation; 1996 Oct 15; 62(7):986-94. PubMed ID: 8878394 [Abstract] [Full Text] [Related]